[HTML][HTML] In silico drug repurposing in COVID-19: A network-based analysis

P Sibilio, S Bini, G Fiscon, M Sponziello, F Conte… - Biomedicine & …, 2021 - Elsevier
The SARS-CoV-2 pandemic is a worldwide public health emergency. Despite the beginning
of a vaccination campaign, the search for new drugs to appropriately treat COVID-19 …

[HTML][HTML] Network bioinformatics analysis provides insight into drug repurposing for COVID-19

X Li, J Yu, Z Zhang, J Ren, AE Peluffo, W Zhang… - Medicine in Drug …, 2021 - Elsevier
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While
developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 …

SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19

G Fiscon, F Conte, L Farina, P Paci - PLoS computational biology, 2021 - journals.plos.org
The novelty of new human coronavirus COVID-19/SARS-CoV-2 and the lack of effective
drugs and vaccines gave rise to a wide variety of strategies employed to fight this worldwide …

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Y Zhou, Y Hou, J Shen, Y Huang, W Martin, F Cheng - Cell discovery, 2020 - nature.com
Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus
(SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead …

[HTML][HTML] Integrating heterogeneous data to facilitate COVID-19 drug repurposing

LP Santamaría, MD Uzquiano, EU Carro… - Drug Discovery …, 2022 - Elsevier
In the COVID-19 pandemic, drug repositioning has presented itself as an alternative to the
time-consuming process of generating new drugs. This review describes a drug repurposing …

Drug repurposing for COVID-19 treatment by integrating network pharmacology and transcriptomics

DY Liu, JC Liu, S Liang, XH Meng, J Greenbaum… - Pharmaceutics, 2021 - mdpi.com
Since coronavirus disease 2019 (COVID-19) is a serious new worldwide public health crisis
with significant morbidity and mortality, effective therapeutic treatments are urgently needed …

A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection

SZ Mousavi, M Rahmanian, A Sami - Infection, Genetics and Evolution, 2020 - Elsevier
Aims The recent outbreak of COVID-19 has become a global health concern. There are
currently no effective treatment strategies and vaccines for the treatment or prevention of this …

Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach

T Loganathan, S Ramachandran, P Shankaran… - PeerJ, 2020 - peerj.com
Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has been declared a pandemic by the World Health …

In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential …

A Lopez-Cortes, P Guevara-Ramirez… - Frontiers in …, 2021 - frontiersin.org
Background: There is pressing urgency to identify therapeutic targets and drugs that allow
treating COVID-19 patients effectively. Methods: We performed in silico analyses of immune …

[HTML][HTML] Drug repurposing for COVID-19 using graph neural network with genetic, mechanistic, and epidemiological validation

K Hsieh, Y Wang, L Chen, Z Zhao, S Savitz… - Research …, 2020 - ncbi.nlm.nih.gov
Amid the pandemic of 2019 novel coronavirus disease (COVID-19) infected by SARS-CoV-
2, a vast amount of drug research for prevention and treatment has been quickly conducted …